{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Control&page=28", "query": { "intervention": "Vehicle Control", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 1096, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Control&page=29&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Control&page=27&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T15:54:00.959Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06830863", "title": "A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "EGFR Inhibitor-associated Rash" ], "interventions": [ { "name": "ATR04-484", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Azitra Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2025-08-25", "completion_date": "2027-09-15", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 6, "location_summary": "Hot Springs, Arkansas • New Haven, Connecticut • New York, New York + 3 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New York", "state": "New York" }, { "city": "Gahanna", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06830863" }, { "nct_id": "NCT00006994", "title": "S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer-related Problem/Condition", "Head and Neck Cancer", "Pain" ], "interventions": [ { "name": "glutamine", "type": "DIETARY_SUPPLEMENT" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "l-glutamine placebo", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "RADIATION", "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 23, "start_date": "2001-11", "completion_date": "2006-04", "has_results": false, "last_update_posted_date": "2015-11-18", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 106, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 68 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006994" }, { "nct_id": "NCT07128628", "title": "A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "Lifitegrast/Perfluorohexyloctane Fixed Dose Combination", "type": "DRUG" }, { "name": "Lifitegrast", "type": "DRUG" }, { "name": "Perfluorohexyloctane", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 443, "start_date": "2025-10-24", "completion_date": "2026-05-28", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 32, "location_summary": "Phoenix, Arizona • Glendale, California • Long Beach, California + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07128628" }, { "nct_id": "NCT01488019", "title": "Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Perforomist-Placebo", "type": "DRUG" }, { "name": "Perforomist, nebulization, COPD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1071, "start_date": "2012-03", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-06-12", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 1, "location_summary": "Greenville, South Carolina", "locations": [ { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01488019" }, { "nct_id": "NCT03918915", "title": "The Safety and Efficacy of SYD-101 in Children With Myopia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nearsightedness", "Near Sightedness", "Near-sightedness" ], "interventions": [ { "name": "SYD-101 0.01%", "type": "DRUG" }, { "name": "SYD-101 0.03%", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sydnexis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "14 Years", "sex": "ALL", "summary": "3 Years to 14 Years" }, "enrollment_count": 852, "start_date": "2019-04-24", "completion_date": "2025-05-01", "has_results": true, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 41, "location_summary": "Irwindale, California • Pasadena, California • San Diego, California + 35 more", "locations": [ { "city": "Irwindale", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Barbara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03918915" }, { "nct_id": "NCT04530344", "title": "Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vitiligo" ], "interventions": [ { "name": "ruxolitinib", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 458, "start_date": "2020-09-24", "completion_date": "2022-11-14", "has_results": true, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 44, "location_summary": "Hoover, Alabama • Gilbert, Arizona • Fountain Valley, California + 36 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04530344" }, { "nct_id": "NCT04475432", "title": "Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Blepharitis" ], "interventions": [ { "name": "TP-03, 0.25%", "type": "DRUG" }, { "name": "TP-03 Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tarsus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2020-09-09", "completion_date": "2021-05-04", "has_results": true, "last_update_posted_date": "2023-12-21", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Newport Beach, California • Colorado Springs, Colorado + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Carmel", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04475432" }, { "nct_id": "NCT01290367", "title": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Degenerative Disc Disease" ], "interventions": [ { "name": "Single Dose MPCs Injection", "type": "BIOLOGICAL" }, { "name": "Single injection of saline solution", "type": "PROCEDURE" }, { "name": "Single injection of hyaluronic acid", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Mesoblast, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2011-08", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2020-06-26", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 13, "location_summary": "Scottsdale, Arizona • Sacramento, California • Santa Monica, California + 10 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01290367" }, { "nct_id": "NCT00361881", "title": "Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Labialis" ], "interventions": [ { "name": "ME-609", "type": "DRUG" }, { "name": "acyclovir in ME-609 vehicle", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medivir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1443, "start_date": "2006-07", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-08-18", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 1, "location_summary": "Mt. Pleasant, South Carolina", "locations": [ { "city": "Mt. Pleasant", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361881" }, { "nct_id": "NCT01682811", "title": "Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neurofibromatoses" ], "interventions": [ { "name": "Part 1 Levulan injection", "type": "DRUG" }, { "name": "Part 1 Levulan surface application", "type": "DRUG" }, { "name": "Part 1 Levulan surface application twice", "type": "DRUG" }, { "name": "Part 1 Levulan surface application twice with microneedling", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harry T Whelan, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 20, "start_date": "2012-03-12", "completion_date": "2016-07-07", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-10-20T15:54:00.959Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01682811" } ] }